Physostigmine: Difference between revisions
No edit summary Tag: mobile edit |
No edit summary Tag: mobile edit |
||
| Line 10: | Line 10: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
*.02mg/kg | *.02mg/kg repeat every 5-10 minutes until adequate response, max of 2 mg | ||
* no faster than .5 mg/min | |||
==Special Populations== | ==Special Populations== | ||
Revision as of 21:03, 30 December 2015
General
- Type: acetylcholinesterase inhibitor
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Anticholinergic toxicity
- 0.5-2mg IV over 5min
Pediatric Dosing
- .02mg/kg repeat every 5-10 minutes until adequate response, max of 2 mg
- no faster than .5 mg/min
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
- Side effects: bradycardia, dysrhythmias, cholinergic excess
- Always have atropine at the bedside for bradycardia or cholinergic excess
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
- Onset of action: 15-20min